IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
IDEXX Laboratories (NASDAQ:IDXX) executives highlighted the company’s diagnostic innovation pipeline, recurring-revenue growth and commercial investments dur...
Search
Search covers the most recently published. For the full archive, browsethe topics.
1 result for"Cancer Dx"